🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the efficacy, safety and tolerability of MK-0928 in Pri...
Status
Terminated
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00266357
To evaluate the safety and tolerability of gaboxadol in primary insomnia....
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00209963
Treatments Being Tested
The purpose of the study is to test the safety and effectiveness of the Inv...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00094627
Treatments Being Tested
The purpose of this trial is to study the safety and effectiveness of MK092...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00095069
To evaluate the efficacy safety and tolerability of gaboxadol in primary in...
Status
Completed
Location
Multiple Locations
Start Date
2003-01
Trial ID
NCT00209937
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of oral OV10...
Status
Completed
Location
Ovid Therapeutics Investigative Site
Start Date
2019-09-09
Trial ID
NCT04106557
The purpose of this trial is to study the safety of MK0928 on insomnia in t...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00095043
Treatments Being Tested
The purpose of the study is to assess the safety and tolerability of oral O...
Status
Completed
Location
Ovid Therapeutics Investigative Site
Start Date
2016-01
Trial ID
NCT02996305
Treatments Being Tested
A study to evaluate the efficacy, safety and tolerability of MK-0928 in Pri...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00266344
Treatments Being Tested
To evaluate the efficacy safety and tolerability of gaboxadol in primary in...
Status
Completed
Location
Non-US study, principal location:
Start Date
2004-04
Trial ID
NCT00209924
Treatments Being Tested